708.29 MCNY
4.33 BCNY
341.41 M
About JIANGZHONG PHARMACEUTICAL
Sector
CEO
Wen Bin Xiao
Headquarters
Nanchang
Website
Employees (FY)
4.01 K
Founded
1996
ISIN
CNE000000M80
FIGI
BBG000BNH2F7
Jiangzhong Pharmaceutical Co., Ltd. engages in the manufacture & distribution of pharmaceutical products. It focuses on research & development, production and sales of chinese patent medicine and health food. Its products include non-prescription drugs and prescription drug. The non-prescription drugs covered the advertising variety such as stomachi and lactobacillus tablets. The prescription drugs lumbrokinase enteric capsules, hemorrhoid treatment tablets and chest relax granules. The company was founded on September 18, 1996 and is headquartered in Nanchang, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 600750 is 26.86 CNY — it has decreased by 0.44% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange JIANGZHONG PHARMACEUTICAL stocks are traded under the ticker 600750.
JIANGZHONG PHARMACEUTICAL is going to release the next earnings report on Apr 27, 2024. Keep track of upcoming events with our Earnings Calendar.
600750 stock is 1.91% volatile and has beta coefficient of 0.56. Check out the list of the most volatile stocks — is JIANGZHONG PHARMACEUTICAL there?
JIANGZHONG PHARMACEUTICAL revenue for the last quarter amounts to 603.63 M CNY despite the estimated figure of 603.63 M CNY. In the next quarter revenue is expected to reach 562.69 M CNY.
Yes, you can track JIANGZHONG PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
600750 stock has fallen by 1.43% compared to the previous week, the month change is a 16.73% rise, over the last year JIANGZHONG PHARMACEUTICAL has showed a 16.78% increase.
600750 net income for the last quarter is 115.97 M CNY, while the quarter before that showed 142.47 M CNY of net income which accounts for −18.61% change. Track more JIANGZHONG PHARMACEUTICAL financial stats to get the full picture.
Today JIANGZHONG PHARMACEUTICAL has the market capitalization of 16.87 B, it has decreased by 0.07% over the last week.
JIANGZHONG PHARMACEUTICAL dividend yield was 6.23% in 2023, and payout ratio reached 114.79%. The year before the numbers were 7.96% and 119.89% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 600750 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JIANGZHONG PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 4.01 K employees. See our rating of the largest employees — is JIANGZHONG PHARMACEUTICAL on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JIANGZHONG PHARMACEUTICAL technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JIANGZHONG PHARMACEUTICAL stock shows the strong buy signal. See more of JIANGZHONG PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on JIANGZHONG PHARMACEUTICAL future price: according to them, 600750 price has a max estimate of 32.00 CNY and a min estimate of 29.24 CNY. Read a more detailed JIANGZHONG PHARMACEUTICAL forecast: see what analysts think of JIANGZHONG PHARMACEUTICAL and suggest that you do with its stocks.